Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin in premenopausal women with severe polycystic liver disease
NL-OMON50796Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of leuprolide in Polycystic liver disease (PLD) (2 arms), sponsored by University Medical Center Groningen. Started Dec 2022; status: recruiting.
02
Drugs
leuprolide
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on NL-OMON50796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50796.